1. Report Overview

1.1 Overview of the World Market for Clinical Trial Supply and Logistics

1.2 Benefits of This Report

1.3 How This Report Delivers

1.4 Main Questions Answered by This Analysis

1.5 Who Is This Study For?

1.6 Methods of Research and Analysis

1.7 Frequently Asked Questions (FAQs)

1.8 Some Related Reports

1.9 About Visiongain

2. Defining the Clinical Trial Supply and Logistics Market

2.1 An Introduction to the Clinical Trial Supply and Logistics Market

2.2 Clinical Trials Are Becoming Increasingly Complex

2.3 Clinical Trial Globalisation: Access to New Markets and New Patients

2.4 Outsourcing Clinical Trial Supply and Logistics

2.5 What Services Are Most Commonly Outsourced?

2.6 Which Companies Participate in the Clinical Trial Supply and Logistics Market?

2.7 Clinical Trial Supply and Logistics: Trends and Future Outlook

3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2017-2027

3.1 The World Clinical Trial Supply and Logistics Market 2016

3.1.1 Which Were the Leading Market Sectors in 2016?

3.2 The World Clinical Trial Supply and Logistics Market Forecast 2017-2027

3.2.1 What Will Drive Market Growth to 2027?

3.2.2 Clinical Trial Supply and Logistics: Market Restraints 2017-2027

3.3 Clinical Trial Manufacturing Submarket 2017-2027

3.3.1 Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2017-2027

3.3.2 Complex Manufacturing and Packaging to Drive Growth 2017-2027

3.3.3 Clinical Trial Packaging Submarket Forecast 2017-2027

3.4 Clinical Trial Logistics and Distribution Submarket 2017-2027

3.4.1 Clinical Trial Logistics and Distribution Submarket Forecast 2017-2027

3.4.2 Clinical Trial Logistics and Distribution: Drivers and Restraints 2017-2027

3.4.3 Clinical Trial Cold Chain Distribution Submarket Forecast 2017-2027

3.5 Clinical Trial Supply Chain Management Submarket 2017-2027

3.5.1 Clinical Trial Supply Chain Management Submarket Forecast 2017-2027

3.5.2 Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2017-2027

4. Leading National Markets for Clinical Trial Supply and Logistics 2017-2027

4.1 Defining National Submarkets for Clinical Trial Supply and Logistics

4.2 Leading National Submarkets for Clinical Trial Supply and Logistics 2016

4.2.1 How Will These Leading Submarkets Grow 2017-2027?

4.3 The US: Clinical Trial Supply and Logistics Market, 2017-2027

4.3.1 How Will Demand for Clinical Trial Logistics Grow in the US to 2027?

4.4 EU5 Markets for Clinical Trial Supply and Logistics, 2017-2027

4.4.1 The Clinical Trial Supply and Logistics Market for Germany: 2017-2027

4.4.2 France: Clinical Trial Supply and Logistics Market, 2017-2027

4.4.3 The UK: Clinical Trial Supply and Logistics Market, 2017-2027

4.4.4 Italy: Clinical Trial Supply and Logistics Market, 2017-2027

4.4.5 Spain: Clinical Trial Supply and Logistics Market, 2017-2027

4.5 Japan: A New and Growing Market for Outsourced Logistics

4.5.1 Japanese Clinical Trial Supply and Logistics Submarket Forecast 2017-2027

4.6 Clinical Trials Increasing Demand in Emerging National Markets

4.7 China: Clinical Trial Supply and Logistics Market, 2017-2027

4.7.1 Foreign Investment in Chinese Clinical Trial Logistics

4.7.2 Strong Growth for Clinical Trial Supply and Logistics in China 2017-2027

4.8 India: An Emerging Destination for Outsourced Clinical Trials

4.8.1 New Clinical Trial Rules Restrain Growth in 2015

4.8.2 India: Clinical Trial Supply and Logistics Market, 2017-2027

4.9 The Latin American Clinical Trial Supply and Logistics Market

4.9.1 Challenging Distribution Conditions

4.9.2 Brazil: Clinical Trial Supply and Logistics Market, 2017-2027

4.10 Russia: Clinical Trial Supply and Logistics Market, 2017-2027

4.10.1 Russia Benefiting from Close Proximity to European Union

4.10.2 Outsourcing Will Grow Strongly in Russia

5. Clinical Trial Supply and Logistics: Regulatory Outlook 2017-2027

5.1 How do Regulatory Standards Affect Clinical Trial Supply?

5.1.1 Good Practices (GxP) in Clinical Trial Distribution

5.1.1.1 Good Manufacturing Practice (GMP)

5.1.1.2 Good Distribution Practice (GDP)

5.1.2 Import Regulations Complicate International Manufacturing and Trials

5.2 Clinical Trial Supply Regulations in the US 2016

5.2.1 Importing Drugs into the US: A Reinterpretation of the Rules

5.3 Clinical Trial Regulations in the EU 2016

5.3.1 Manufacturing Requirements for Clinical Trial Materials in the EU

5.3.2 The European Commission Releases New GDP Guidelines 2013

5.4 GMP and Importation Regulations for Pharmaceuticals in Japan 2016

5.5 Clinical Trial Supply Chain Regulations in Emerging Markets

5.5.1 China: Tougher Regulations for Pharmaceutical Companies and Service Providers

5.5.1.1 Improving Supply Chain Security in China 2015

5.5.2 India: Drug Manufacturing and Imports for Clinical Trials

5.5.2.1 The CDSCO Drafts New GDP Guidelines

5.5.3 Brazil: Slow Regulatory Approval for Clinical Trials

5.5.4 Recent Updates to Pharmaceutical Regulation in Russia

6. Clinical Trial Supply and Logistics: Industry Trends 2017-2027

6.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2016

6.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats 2017-2027

6.3 Clinical Trial Supply and Logistics Market: STEP Analysis 2017-2027

6.3.1 Social Factors

6.3.2 How Will Novel Technologies Affect the Market to 2027?

6.3.3 Economic Pressure: Demands for Lower Cost Trials and Logistics

6.3.4 Political Issues

6.4 Securing the Clinical Trial Supply Chain 2017-2027

6.4.1 How Will Technology Improve Supply Chain Security?

6.5 How Will Clinical Trial Globalisation Impact Supply and Logistics?

6.6 Trends in Clinical Trial Manufacturing 2017-2027

6.6.1 The Challenge of Comparator Sourcing for Clinical Trials

6.6.1.1 Comparators Are a Source of Risk for Supply Chain Security

6.6.1.2 Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research

6.6.2 Trends in Packaging for Clinical Trials 2017-2027

6.7 Clinical Trial Supply Chain Management Trends to 2027

6.7.1 Forecasting and Modelling to Ensure Sufficient Supply

6.7.2 IT Systems Improve Clinical Trial Planning: IVRS and IWRS

6.7.3 Home-Based Trial Participation: Opportunities and Challenges for Logistics

6.7.4 How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?

6.8 Outsourcing Clinical Trial Supply and Logistics

6.8.1 Managing Multiple Supplier Networks

7. The Rise of Cold Chain Logistics in Clinical Trials 2017-2027

7.1 An Introduction to Cold Chain Supply and Distribution

7.1.1 The Importance of Cold Chain for Clinical Trials

7.1.2 Maintaining the Cold Chain

7.2 The Regulatory Outlook for Cold Chain Logistics

7.2.1 International Air Transport Regulations and Guidance: The Temperature Sensitive Label

7.3 Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2017-2027

7.3.1 Biologic Drug Development Will Stimulate Demand

7.3.1.1 Emerging Trends in Biological Drug Development

7.3.2 Pharma Cold Chain Logistics in Emerging Markets

7.4 The Role of Technology in Clinical Cold Chain Logistics

7.4.1 Active and Passive Temperature Control

7.4.2 There Are Many Ways to Maintain Temperature in the Cold Chain

7.4.2.1 Developments in Phase Change Materials

7.4.2.2 The Benefits of Liquid Nitrogen for Sample Transportation

7.4.3 Advances in RFID for Temperature Monitoring

7.4.3.1 Will Uptake for RFID Grow Among Biopharma Companies to 2027?

7.4.4 Future Technologies for Cold Chain Supply Management

7.4.4.1 Demand for Reusable Cold Chain Packaging

8. Clinical Trial Supply and Logistics Market: Leading Companies

8.1 Third Party Logistics Providers: Leading Clinical Distributors

8.1.1 World Courier: A Pharmaceutical Supply Specialist

8.1.1.1 Distribution Services for Pharma, CROs and Central Laboratories

8.1.1.2 World Courier Is the Clinical Trial Distribution Market Leader

8.1.1.3 World Courier Service Expansion: New Facility Opened at Melbourne, Australia

8.1.2 DHL: A Global Leader in Supply Chain Logistics

8.1.2.1 Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain

8.1.2.2 DHL Adds New Services for Healthcare and Clinical Trial Clients 2015

8.1.3 Marken: A leader in Direct to Patient Services

8.1.3.1 What Services Does Marken Offer Clinical Trial Sponsors?

8.1.3.2 Marken: Challenging Market Conditions 2010-2015

8.1.3.3 Marken Continues to Expand Worldwide

8.1.3.4 Expertise in Biological Sample Management

8.1.4 Other Leading and Emerging Players in the Market 2015

8.1.4.1 TNT Express

8.1.4.2 FedEx

8.1.4.3 Movianto - A European Healthcare Specialist

8.2 Clinical Trial Manufacturing: Submarket Leaders

8.2.1 Catalent Pharma Solutions

8.2.1.1 Clinical Trial Manufacturing and Supply Services

8.2.1.2 Strong Growth for Clinical Manufacturing Revenue

8.2.1.3 Catalent Expanding its Clinical Supply Services

8.2.2 Patheon

8.2.2.1 Patheon – Global leader in Pharmaceutical Development Services

8.2.2.2 Patheon Clinical Projects

8.2.3 Almac Group: Manufacturing, Packaging and Logistics Services

8.2.3.1 Clinical Trial Supply and Management Solutions

8.2.3.2 Almac Opens New Facilities to Expand its Clinical Trial Expertise

8.3 The Role of CROs in the Clinical Trial Supply and Logistics Market

8.3.1 Parexel International

8.3.1.1 Parexel’s Clinical Trial Supply and Logistics Services

8.3.1.2 Parexel Expands Worldwide

8.4 Other Leading Companies in the Clinical Trial Supply and Logistics Market 2015

8.4.1 Fisher Clinical Services (FCS)

8.4.1.1 FCS Offers Manufacturing, Packaging, Storage and Distribution Services

8.4.1.2 Fisher BioServices: Clinical Logistics for the Cell Therapy Industry

8.4.2 Packaging Coordinators Inc. (PCI)

9. Research Interview, 2017

9.1 Ms. Ariette van Strien, Chief Commercial Officer, Marken, US

9.1.1 Marken

9.1.2 Marken’s Business Milestones in 2016 and 2017

9.1.3 Marken – a Wholly Owned Subsidiary of UPS

9.1.4 New Operating Licenses in Argentina

9.1.5 Leading in Direct-to-Patient Services and Biological Sample Shipments

10. Conclusions of Our Study

10.1 The Clinical Trial Supply and Logistics Market in 2016

10.2 Outlook for the Market, 2017-2027

10.3 Growing Demand for Clinical Logistics in Emerging Countries

10.4 Technology and Innovation to Drive Outsourcing

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Report Evaluation Form

List of Tables

Table 1.1 Clinical Trial Supply and Logistics Market: Overall Market and Revenue Forecasts by Sector ($bn), 2016-2027 (Sample Table)

Table 2.1 Clinical Trials Registered by Country/Region, November 2016

Table 3.1 R&D Outsourcing Market: Submarket Size ($bn) and Market Share (%) by Sector, 2016

Table 3.2 Clinical Trial Supply and Logistics Market: Submarket Size ($bn) and Market Share (%) by Sector, 2016

Table 3.3 Clinical Trial Supply and Logistics Market Revenue Forecast by Sector: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021

Table 3.4 Clinical Trial Supply and Logistics Market Revenue Forecasts by Sector: Revenue ($bn), AGR (%) and CAGR (%), 2021-2027

Table 3.5 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2016-2027

Table 3.6 Clinical Trial Manufacturing Submarket: Submarket Size ($bn) and Submarket Share (%) by Sector, 2016

Table 3.7 Clinical Trial Manufacturing Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021

Table 3.8 Clinical Trial Manufacturing Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2021-2027

Table 3.9 Clinical Trial Packaging Submarket: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 3.10 Clinical Trial Logistics and Distribution Market: Submarket Size ($bn) and Submarket Share (%) by Sector, 2016

Table 3.11 Clinical Trial Logistics and Distribution Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021

Table 3.12 Clinical Trial Logistics and Distribution Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2021-2027

Table 3.13 Clinical Trial Cold Chain Logistics Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 3.14 Clinical Trial Supply Chain Management Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.1 Clinical Trial Supply and Logistics Market: Market Size ($bn) and Market Shares (%) by Leading Country and Region, 2016

Table 4.2 Clinical Trial Supply and Logistics Market: Country Submarket Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.3 Clinical Trial Supply and Logistics Market: Leading National Market Share (%), 2016, 2021 and 2027

Table 4.4 US Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Table 4.5 EU5 Clinical Trial Supply and Logistics: Submarket Revenue Forecasts ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.6 The EU5 Clinical Trial Supply and Logistics Submarket: Market Size ($bn) and Market Shares (%), 2016

Table 4.7 Germany: Clinical Trial Supply and Logistics Market: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.8 France Clinical Trial Supply and Logistics Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.9 The UK: Clinical Trial Supply and Logistics Market: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.10 Italy: Clinical Trial Supply and Logistics Market: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.11 Spain: Clinical Trial Supply and Logistics Market: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.12 Japan: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.13 Selected Clinical Trial Logistics Investments in China, 2011-2015

Table 4.14 China: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.15 India: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.16 Selected Clinical Trial Logistics Investments in Latin America, 2012-2015

Table 4.17 Brazil: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2016-2027

Table 4.18 Russia: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2015-2026

Table 5.1 ICH Manufacturing Guidelines, 2001-2012

Table 6.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses, 2017-2027

Table 6.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats, 2017-2027

Table 6.3 Clinical Trial Supply and Logistics Market: STEP Analysis, 2017-2027

Table 6.4 Commonwealth of Independent States: Registered Clinical Trials, 2014

Table 6.5 Comparative Costs of Orphan and Non-Orphan Clinical Trials, 2015

Table 6.6 TransCelerate BioPharma Member Companies, 2015

Table 6.7 Benefits of Advanced Forecasting Tools for Clinical Trial Logistics

Table 6.8 Selected Clinical Trial Supply Forecasting Tools Available, 2016

Table 6.9 Selected IVRS/IWRS Tools Available for Clinical Trials, 2016

Table 6.10 Home-Based Clinical Trial Distribution: Advantages and Disadvantages, 2016

Table 6.11 Outsourcing Clinical Trial Supply and Logistics: Benefits and Weaknesses, 2017

Table 7.1 Top Ten Prescription Drugs: Overall Biologics Share, 2013 and 2019

Table 7.2 Leading Providers of RFID Tags for the Pharmaceutical Market, 2016

Table 8.1 AmerisourceBergen: Other Service Revenue ($m), 2013-2015

Table 8.2 DHL Supply Chain: Revenue ($m) by Sector, 2015

Table 8.3 DHL Life Sciences and Healthcare: Revenue ($m) and AGR (%), 2014-2015

Table 8.4 Marken Historical Revenue: Revenue ($m), Annual Growth (%), CAGR (%) 2010-2014

Table 8.5 Catalent Development and Clinical Services: Revenue ($m), 2011-2015

Table 8.6 Patheon Pharmaceutical Development Projects (%) by Phase, 2016

Table 8.7 Patheon Pharmaceutical Development Services: Revenue ($bn), 2014-2016

Table 8.8 Almac Group: Revenue ($m), 2011-2015

Table 8.9 Parexel: Clinical Research Services Revenue ($m), 2012-2016

Table 10.1 Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2016, 2021 and 2027

Table 10.2 Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Region in 2016, 2021 and 202

List of Figures

Figure 2.1 Sectors and Services in the Clinical Trial Supply and Logistics Market, 2017

Figure 2.2 Clinical Trials Registered by Country/Region, 2016

Figure 2.3 Trends Affecting the Clinical Trial Supply and Logistics Market, 2017-2027

Figure 3.1 Pharma R&D Outsourcing Market: Market Share (%) by Sector, 2016

Figure 3.2 Clinical Trial Supply and Logistics Market: Market Share (%) by Sector, 2016

Figure 3.3 Clinical Trial Supply and Logistics Market Forecast ($bn), 2016-2027

Figure 3.4 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2021

Figure 3.5 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2027

Figure 3.6 Clinical Trial Supply and Logistics: Market Drivers, 2017-2027

Figure 3.7 Clinical Trial Supply and Logistics: Market Restraints, 2017-2027

Figure 3.8 Clinical Trial Manufacturing Market: Sector Shares (%), 2016

Figure 3.9 Clinical Trial Manufacturing Market Forecast ($bn), 2016-2027

Figure 3.10 Clinical Trial Manufacturing: Drivers and Restraints, 2017-2027

Figure 3.11 Clinical Trial Packaging Submarket Forecast ($bn), 2016-2027

Figure 3.12 Clinical Trial Logistics and Distribution Market: Sector Shares (%), 2016

Figure 3.13 Clinical Trial Logistics and Distribution Market Forecast ($bn), 2016-2027

Figure 3.14 Clinical Trial Logistics and Distribution: Drivers and Restraints, 2017-2027

Figure 3.15 Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2016-2027

Figure 3.16 Clinical Trial Supply Chain Management Market Forecast ($bn), 2016-2027

Figure 3.17 Clinical Trial Supply Chain Management: Drivers and Restraints, 2017-2027

Figure 4.1 Clinical Trial Supply and Logistics Market: Market Share (%) by Country and Region, 2016

Figure 4.2 Clinical Trial Supply and Logistics Market: Market Share (%) by Region, 2016, 2021 and 2027

Figure 4.3 US Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.4 US Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.5 US Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.6 EU5 Clinical Trial Supply and Logistics: Overall Revenue ($bn), 2016-2027

Figure 4.7 EU5 Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.8 EU5 Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.9 The EU5 Clinical Trial Supply and Logistics Submarket Shares (%), 2016

Figure 4.10 Germany: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.11 France: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.12 The UK: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.13 Italy: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.14 Spain: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.15 Japan: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.16 Japanese Clinical Trial Supply and Logistics Market Share (%) in 2016, 2021 and 2027

Figure 4.17 Japanese Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.18 China: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.19 Chinese Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.20 Chinese Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.21 India: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.22 Indian Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.23 Indian Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.24 Brazil: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.25 Brazilian Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.26 Brazilian Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 4.27 Russia: Clinical Trial Supply and Logistics Market Revenue ($bn), 2016-2027

Figure 4.28 Russia: Clinical Trial Supply and Logistics Market Share (%), 2016, 2021 and 2027

Figure 4.29 Russian Clinical Trial Supply and Logistics: Drivers and Restraints, 2017-2027

Figure 6.1 Players in the Clinical Trial Supply Chain, 2016

Figure 8.1 AmerisourceBergen Other Service: Revenue ($m), 2015

Figure 8.2 DHL Supply Chain: Revenue Share (%) by Sector, 2015

Figure 8.3 Marken: Revenue ($m), 2010-2014

Figure 8.4 Catalent: Clinical Manufacturing Space by Region (%), 2015

Figure 8.5 Catalent Development and Clinical Services: Revenue ($m), 2011-2015

Figure 8.6 Patheon Pharmaceutical Development Projects (%) by Phase, 2016

Figure 8.7 Patheon Pharmaceutical Development Services: Revenue ($bn), 2014-2016

Figure 8.8 Almac Group: Revenue ($m), 2011-2015

Figure 8.9 Parexel: Clinical Research Services Revenue ($m), 2012-2016

Figure 10.1 Clinical Trial Supply and Logistics Market: Revenue ($bn) by Sector, 2016, 2021 and 2027

Figure 10.2 Clinical Trial Supply and Logistics Market: Revenue ($bn) by Region, 2016, 2021 and 2027